Follow
Hamed Zolfagharifard
Hamed Zolfagharifard
Alzahra Research Institute, Isfahan University of Medical sciences
No verified email
Title
Cited by
Cited by
Year
SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: same story, different vaccine
M Etemadifar, N Sedaghat, H Nouri, N Lotfi, A Chitsaz, R Khorvash, ...
Multiple Sclerosis and Related Disorders 57, 103417, 2022
212022
Weight Loss and Loss of Appetite as a Side Effect of Fingolimod
M Etemadifar, R Khorvash, H Zolfagharifard, N Sedaghat, H Nouri, ...
12022
The system can't perform the operation now. Try again later.
Articles 1–2